Back
Biogen, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
46
BIIB
Biogen, Inc.
Last Price:
$171.41
Seasonality Move:
6.44%
Sell
33
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.94
Seasonality Move:
-8.13%
Sell
46
Biogen, Inc. (BIIB)
is a Sell
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $171.50. The Score for BIIB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $171.50The current trend is moderately bearish and BIIB is experiencing slight selling pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $32.59The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.6 | Buy |
| Relative Strength Index (14 RSI): | 49.95 | Sell |
| Chaikin Money Flow: | -497143 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (167.21 - 180.85) | Sell |
| Bollinger Bands (100): | (134.12 - 166) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.39 | Buy |
| Relative Strength Index (14 RSI): | 42.51 | Sell |
| Chaikin Money Flow: | -433025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 176.12 | Sell |
| 20-day SMA: | 176.64 | Sell |
| 50-day SMA: | 161.67 | Buy |
| 200-day SMA: | 139.65 | Buy |
| 8-day EMA: | 175.26 | Sell |
| 20-day EMA: | 173.77 | Sell |
| 50-day EMA: | 164.51 | Buy |
| 200-day EMA: | 151.6 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.44 | Sell |
| 20-day SMA: | 37.66 | Sell |
| 50-day SMA: | 32.27 | Buy |
| 200-day SMA: | 17.45 | Buy |
| 8-day EMA: | 37.61 | Sell |
| 20-day EMA: | 34.32 | Sell |
| 50-day EMA: | 23.15 | Buy |
| 200-day EMA: | 7.97 | Buy |
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.30 per share, and an increase next year of $0.12 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Biogen, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||